Istradefylline

Istradefylline
Systematic (IUPAC) name
	8-[(E)-2-(3,4-dimethoxyphenyl)vinyl]-1,3-diethyl-7-methyl-3,7-dihydro-1H-purine-2,6-dione
Identifiers
CAS Number	155270-99-8
ATC code	none
PubChem	CID: 5311037
IUPHAR/BPS	5608
ChemSpider	4470574
UNII	2GZ0LIK7T4
KEGG	D04641
ChEMBL	CHEMBL431770
Chemical data
Formula	C20H24N4O4
Molecular mass	384.429 g/mol
	SMILES O=C2N(c1nc(n(c1C(=O)N2CC)C)\C=C\c3ccc(OC)c(OC)c3)CC ;
	InChI InChI=1S/C20H24N4O4/c1-6-23-18-17(19(25)24(7-2)20(23)26)22(3)16(21-18)11-9-13-8-10-14(27-4)15(12-13)28-5/h8-12H,6-7H2,1-5H3/b11-9+ ; Key:IQVRBWUUXZMOPW-PKNBQFBNSA-N ;
(verify)

Istradefylline (KW-6002) is a selective antagonist at the A_2A receptor. It has been found to be useful in the treatment of Parkinson's disease.^[1] Istradefylline reduces dyskinesia resulting from long-term treatment with classical antiparkinson drugs such as levodopa. Istradefylline is an analog of caffeine.

References

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.